Navigation Links
MDS Pharma Services Names Dr. Lori McDonald to Executive Leadership Team
Date:6/26/2008

Experienced leader will head Quality & Compliance function at leading

contract research organization

KING OF PRUSSIA, PA, June 26 /PRNewswire-FirstCall/ - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has hired Dr. Lori McDonald as Vice President, Quality & Compliance. Dr. McDonald will lead MDS Pharma Services' ongoing program to build and manage quality and regulatory compliance systems across its global business platforms.

"I'm delighted that Dr. McDonald has joined our leadership team," said MDS Pharma Services President David Spaight. "By enabling process improvements and compliance with regulatory requirements, she and her staff will be instrumental in helping MDS Pharma Services deliver high-quality, on-time services. This will help our clients expedite their drug discovery and development programs."

Dr. McDonald brings strong credentials to this key leadership position. Before joining MDS she served as Vice President, Regulatory Affairs with Alder Biopharmaceuticals. From 2001 to 2006, Dr. McDonald held a series of leadership roles with Cardinal Health, culminating as Executive Director, Regulatory Affairs. Prior to that, she worked at Ligand Pharmaceuticals and Abbott Laboratories.

Dr. McDonald holds a B.S. in Medical Technology from the University of North Dakota, and both an M.S. and a Ph. D. in Pharmaceutics from the University of Michigan. She also holds a Regulatory Affairs Certification, which is administered by the Regulatory Affairs Professionals Society.

About MDS Pharma Services

MDS Pharma Services is committed to delivering quality service on time. We offer a full spectrum of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With numerous facilities strategically located around the world, we apply advanced scientific and technological expertise throughout the drug d
'/>"/>

SOURCE MDS Pharma Services
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Avalon Pharmaceuticals names lead development candidate in beta-catenin inhibitor program
2. KV Pharmaceutical Company Completes Fiscal 2008 Filings With Securities and Exchange Commission
3. Fischman receives Pharmacology/Therapeutics/Toxicology Research Award
4. Catalyst Pharmaceutical Partners, Inc. Set to Join Russell Microcap(R) Index
5. Microsoft Announces Winners of the 2008 Pharmaceutical and Life Sciences Innovation Awards
6. CEVA Logistics Awarded Best 3PL Provider for Pharmaceutical, Chemical, HazMat and Fresh Food Supply Chains
7. NACDS Praises House Legislation to Delay Medicaid Cuts, Aid Pharmacies in Treating Patients
8. The MedZilla Report: May 2008 Employment Outlook for Biotech/Pharma/Health
9. 1 step closer to green chemistry and improved pharmaceuticals
10. Pharmavite Partners With LearnSomething, Inc. on Consumer Education Program, LearnSomethingAbout(TM)
11. MAP Pharmaceuticals Acquires Proprietary Drug Particle Formulation Technology From Eiffel/Telesso Technologies Limited
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
(Date:12/4/2009)Move a response to pressure from federal regulators to crack down on abuse of opioid medications , , FRIDAY, Dec. 4 (HealthDay News) -- The makers of 24 different prescription painkillers on F
Breaking Medicine News(10 mins):Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Makers of Powerful Painkillers Present Safety Plans 2
... child spikes a high fever, sometimes as high as 1... Shes rushed to the emergency room, the hospital r...ut no explanation is found. , Many families thou...nt respond to antibiotics or fever reducers like M...
...Magazine urges readers to participate in nationwid...IA, March 28 Smart Genetics has,announced that PA...art of a,nationwide poll asking readers if they wa...lligenc ,e_Report#health., PARADE, the nation,s m...
...ease in specific white blood cells could warn doct... March 28 (HealthDay News) -- Researchers at Templ...ker that denotes the progression of the virus that...s (HIV), according to a study published in the Mar...
...ASHINGTON, March 28 Richard T. Clark, Chief,Execu...oard chairman of the,Pharmaceutical Research and M... association,s annual meeting. Also elected were A...frey B.,Kindler as board treasurer., In addition,...
...lunt cerebrovascular injuries can be diagnosed usi...no need for an additional neck MDCT angiography ex... researchers at the University of Maryland Medical...In the past, blunt trauma patients would undergo w...
...hiladelphia, March 28, 2008 Many parents are conv...re different than those of children and adults. Ne...by Jay N. Giedd, MD, of the National Institute of ... cognition, emotion and behavior. , Dr. Giedd rev...
Other Medicine News:Health News:Mysterious fevers of unknown origin: Could surgery be a cure? 2Health News:PARADE Magazine Features Smart Genetics and Alzheimer's Mirror 2Health News:Biomarker May Signal HIV Progression 2Health News:Richard T. Clark Elected PhRMA Board Chairman 2Health News:Richard T. Clark Elected PhRMA Board Chairman 3Health News:Richard T. Clark Elected PhRMA Board Chairman 4Health News:Richard T. Clark Elected PhRMA Board Chairman 5Health News:Whole body MDCT just as 'good' as neck MDCT angiography in diagnosing head and neck injuries 2Health News:Are teenage brains really different? 2Health News:Are teenage brains really different? 3
(Date:12/4/2009)BILLERICA, Mass., Dec. 4 Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: VOLC ), today announced the initial development and successful testing of a novel integra
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Drs. Neal Shore and E. David Crawford presented results for prostate-specific antigen (PSA) recurrence from the additional analysis of secondary end points of biochemical recurr
(Date:12/3/2009)NEW YORK, Dec. 3 Guidepoint Global, LLC , a leading primary research firm, today announced the launch of their Sleep Apnea Tracker, a monthly longitudinal data release that monitors and projects tre
Breaking Medicine Technology:Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2CardioDynamics Reports Second Fiscal Quarter 2009 Results 51278 1CardioDynamics Reports Second Fiscal Quarter 2009 Results 51278 2CardioDynamics Reports Second Fiscal Quarter 2009 Results 51278 3CardioDynamics Reports Second Fiscal Quarter 2009 Results 51278 4CardioDynamics Reports Second Fiscal Quarter 2009 Results 51278 5Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine 28Resveratrol 29 Pills Issue Consumer Precautions 51276 1Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine 28Resveratrol 29 Pills Issue Consumer Precautions 51276 2Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine 28Resveratrol 29 Pills Issue Consumer Precautions 51276 3Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine 28Resveratrol 29 Pills Issue Consumer Precautions 51276 4AUL President to Senate Judiciary Committee 3A Ask Top 10 Questions to Judge Sotomayor 51274 1AUL President to Senate Judiciary Committee 3A Ask Top 10 Questions to Judge Sotomayor 51274 2
Flammable Chemical Storage Cabinets
BTP/1Q-PAL - Polished Aluminum Base - Model 1Q64-R-PAL
BTP/1Q-PAL - Polished Aluminum Base - Model 1Q43-R-PAL
BTP/1Q-PAL - Polished Aluminum Base - Model 1Q72-R-PAL
Medicine Products: